Tacrolimus er også vist at hæmme frigørelse af inflammations mediatorer fra hudmastceller og fra basofile og eosinofile leukocyter.
Tacrolimus has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils.